Skip to content

A Study on Chronic Sinusitis and the Effectiveness of Unani formulation in its Treatment

A Clinical Study on Warm e tajaweef e anf muzmin (Chronic rhinosinusitis) and the comparative evaluation of Unani formulations in its management. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086758
Enrollment
80
Registered
2025-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Intervention1: Mufeed Joshanda: Each sachet contains Sapistan (Cordia latifolia) : 9 in no. Aslusoos (Glycirrhiza glabra ): 4 gm Barg-e-gaozaban (boraggo officinalis ): 4 gm Unn

Sponsors

Department of Moalejat Ajmal Khan Tibbiya CollegeAligarh Muslim University Aligarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed patients of chronic Rhinosinusitis of not more than 5 years duration. Patients of both sexes. Patients in the age group of 15 to 50 years. Patients with involvement of any sinus. Those who give written consent. Patients complaining of post nasal drip -Subjective Parameters Nasal obstruction Nasal discharge Sneezing Headache Post nasal drip Abnormalities of smell Heaviness in head -Objective Parameters Xray PNS (water s view)

Exclusion criteria

Exclusion criteria: Patients having history of any surgery of nose or paranasal sinuses Patients with Malignancy of the nose or paranasal sinuses. Patients having history of any foreign body in their nose. Pregnant & lactating mothers. Patients who fail to give consent. Patients who fail to follow up.. patient having history of epistaxis. Patient having history of trauma to nose or sinus areas Pregnant & lactating mothers. Patients suffering from any congenital or acquired structural abnormality of the nasal cavity. Any medical condition where physician feels that participation in the study could be detrimental to patient s well being. Patients of pulmonary koch s

Design outcomes

Secondary

MeasureTime frame
Assesment of the opacity in the Xray (PNS) Assesment of the mucosal thickeningTimepoint: 60 days with the baseline and after the completion

Primary

MeasureTime frame
Improvement in objective parameters. Nasal obstruction Nasal discharge Sneezing Headache Post nasal drip Abnormalities of smell Heaviness in head Timepoint: 60 days with baseline and after the completion

Countries

India

Contacts

Public ContactDr Mursaleen Naseer

Ajmal Khan Tibbiya College

drmursaleen@gmail.com9412562724

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026